Literature DB >> 20082119

Anionic linear-globular dendrimers: biocompatible hybrid materials with potential uses in nanomedicine.

Mohammad Shafiee Alavidjeh1, Ismaeil Haririan, Mohammad Reza Khorramizadeh, Zohre Zarei Ghane, Mehdi Shafiee Ardestani, Hassan Namazi.   

Abstract

The use of dendrimers as nano-sized excipients/vectors in biological and pharmaceutical systems is dependent on the investigation of their toxicological profiles in biological media. In this study, a series of mechanistic in vitro structure-associated cell toxicity evaluations was performed on the two generations of an anionic linear-globular dendrimer G1 and G2 (where PEG is the core, and citric acid is the periphery) each of which has a different size, charge, and MW. In vitro cytotoxicity behavior of the dendrimers with the methods like crystal violet staining, methyl thiazolyl tetrazolium (MTT), and lactate dehydrogenase (LDH) assays was analyzed. The cell death mechanisms (apoptosis-necrosis) induced by the dendrimers were also evaluated in HT1080 cell line. The impact of the dendrimers on the release of the pro-inflammatory cytokines like TNF-alpha (tumor necrosis factor alpha) and IL1-beta (interleukin 1 beta) was assessed in THP-1 cell line. Hemolysis assay and coagulation studies such as PT (prothrombin time) and APTT (activated partial thromboplastin time) on human blood samples were conducted to examine the interactions of the dendrimers with such bio-environments. The results of cell cytotoxicity experiments and the amounts of IL1-beta and TNF-alpha secretions from THP-1 cell line were consistent with the hemoglobin release from the erythrocytes and the results gained from the coagulation studies. In fact, no significant harmful effect was observed for the dendrimers up to the concentration of 0.5 mg/ml. Both apoptosis and necrosis were ascribed to cell death. The G1 with more flexibility, less negative charge, and greater poly dispersity in size versus the G2 displayed more toxicity than the G2 at the concentration of 1 mg/ml and above in most of the experiments. As a whole, these results suggest a biocompatible range for these hybrid structures up to the concentration of 0.5 mg/ml. Therefore, the potentiality for these structures to be employed in the different and numerous realms of nanomedicine will be very great.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20082119     DOI: 10.1007/s10856-009-3978-8

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  15 in total

Review 1.  Dendrimers in drug research.

Authors:  Ulrik Boas; Peter M H Heegaard
Journal:  Chem Soc Rev       Date:  2003-12-05       Impact factor: 54.564

2.  Effect of single wall carbon nanotubes on human HEK293 cells.

Authors:  Daxiang Cui; Furong Tian; Cengiz S Ozkan; Mao Wang; Huajian Gao
Journal:  Toxicol Lett       Date:  2005-01-15       Impact factor: 4.372

3.  In vitro biological evaluation of high molecular weight hyperbranched polyglycerols.

Authors:  Rajesh Kumar Kainthan; Samuel R Hester; Elena Levin; Dana V Devine; Donald Elliott Brooks
Journal:  Biomaterials       Date:  2007-08-03       Impact factor: 12.479

4.  Corrections to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cell cytotoxicity.

Authors:  G Konjević; V Jurisić; I Spuzić
Journal:  J Immunol Methods       Date:  1997-01-15       Impact factor: 2.303

5.  Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.

Authors:  D A Flick; G E Gifford
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

6.  Hemocompatibility evaluation of poly(glycerol-sebacate) in vitro for vascular tissue engineering.

Authors:  Delara Motlagh; Jian Yang; Karen Y Lui; Antonio R Webb; Guillermo A Ameer
Journal:  Biomaterials       Date:  2006-05-03       Impact factor: 12.479

7.  Chemical modification of SWNT alters in vitro cell-SWNT interactions.

Authors:  Aditya Nimmagadda; Karen Thurston; Matthias U Nollert; Peter S McFetridge
Journal:  J Biomed Mater Res A       Date:  2006-03-01       Impact factor: 4.396

8.  Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents.

Authors:  H Namazi; M Adeli
Journal:  Biomaterials       Date:  2005-04       Impact factor: 12.479

9.  The influence of surface modification on the cytotoxicity of PAMAM dendrimers.

Authors:  R Jevprasesphant; J Penny; R Jalal; D Attwood; N B McKeown; A D'Emanuele
Journal:  Int J Pharm       Date:  2003-02-18       Impact factor: 5.875

10.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

Authors:  Dagmar Fischer; Youxin Li; Barbara Ahlemeyer; Josef Krieglstein; Thomas Kissel
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

View more
  13 in total

1.  Reduction toxicity of Amphotericin B through loading into a novel nanoformulation of anionic linear globular dendrimer for improve treatment of leishmania major.

Authors:  Tahereh Zadeh Mehrizi; Mehdi Shafiee Ardestani; Ali Khamesipour; Mostafa Haji Molla Hoseini; Nariman Mosaffa; Ali Anissian; Amitis Ramezani
Journal:  J Mater Sci Mater Med       Date:  2018-07-28       Impact factor: 3.896

2.  Novel PH Sensitive Nanocarrier Agents Based on Citric Acid Dendrimers Containing Conjugated β-Cyclodextrins.

Authors:  Hassan Namazi; Yousef Toomari Hamrahloo
Journal:  Adv Pharm Bull       Date:  2011-07-20

3.  Antiplasmodial Effect of Nano Dendrimer G2 Loaded with Chloroquine in Mice Infected with Plasmodium berghei.

Authors:  Taher Elmi; Mehdi Shafiee Ardestani; Manijeh Motevalian; Ali Kalantari Hesari; Mohammad Seyyed Hamzeh; Zahra Zamani; Fatemeh Tabatabaie
Journal:  Acta Parasitol       Date:  2021-08-16       Impact factor: 1.440

4.  Nanosilver based anionic linear globular dendrimer with a special significant antiretroviral activity.

Authors:  Mehdi Shafiee Ardestani; Alireza Salehi Fordoei; Asghar Abdoli; Reza Ahangari Cohan; Golnaz Bahramali; Seyed Mehdi Sadat; Seyed Davar Siadat; Hamid Moloudian; Nasser Nassiri Koopaei; Azam Bolhasani; Pooneh Rahimi; Soheila Hekmat; Mehdi Davari; Mohammad Reza Aghasadeghi
Journal:  J Mater Sci Mater Med       Date:  2015-04-17       Impact factor: 4.727

5.  Fabrication of triblock ABA type peptide dendrimer based on glutamic acid dimethyl ester and PEG as a potential nano drug delivery agent.

Authors:  Hassan Namazi; Yousef Toomari; Hassan Abbaspour
Journal:  Bioimpacts       Date:  2014-11-22

6.  Gd3+-Asparagine-Anionic Linear Globular Dendrimer Second-Generation G2 Complexes: Novel Nanobiohybrid Theranostics.

Authors:  Nasim Hashempour Alamdari; Mahmood Alaei-Beirami; Seyed Ataollah Sadat Shandiz; Hadi Hejazinia; Rahimeh Rasouli; Mostafa Saffari; Seyed Esmaeil Sadat Ebrahimi; Artin Assadi; Mehdi Shafiee Ardestani
Journal:  Contrast Media Mol Imaging       Date:  2017-09-26       Impact factor: 3.161

7.  AS1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics.

Authors:  Pardis Mohammadzadeh; Reza Ahangari Cohan; Seyedeh Masoumeh Ghoreishi; Ahmad Bitarafan-Rajabi; Mehdi Shafiee Ardestani
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

8.  Induction of Immune Responses by DNA Vaccines Formulated with Dendrimer and Poly (Methyl Methacrylate) (PMMA) Nano-Adjuvants in BALB/c Mice Infected with Leishmania major.

Authors:  Fatemeh Tabatabaie; Nasim Samarghandi; Somayeh Zarrati; Fatemeh Maleki; Mehdi Shafiee Ardestani; Taher Elmi; Sayed Hussain Mosawi
Journal:  Open Access Maced J Med Sci       Date:  2018-01-27

9.  PEG-Citrate dendrimer second generation: is this a good carrier for imaging agents In Vitro and In Vivo?

Authors:  Pardis Mohammadzadeh; Mehdi Shafiee Ardestani; Sobhan Mortazavi-Derazkola; Ahmad Bitarafan-Rajabi; Seyedeh Masoumeh Ghoreishi
Journal:  IET Nanobiotechnol       Date:  2019-08       Impact factor: 1.847

10.  Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity.

Authors:  Artin Assadi; Vahideh Sharifi Najafabadi; Seyed Ataollah Sadat Shandiz; Azadah Shayeq Boroujeni; Sepehr Ashrafi; Ali Zaman Vaziri; Seyedeh Masoumeh Ghoreishi; Mohammad Reza Aghasadeghi; Seyed Esmaeil Sadat Ebrahimi; Morteza Pirali-Hamedani; Mehdi Shafiee Ardestani
Journal:  Onco Targets Ther       Date:  2016-09-07       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.